"Das Universitätsklinikum des Saarlandes (UKS) ist mit 30 Kliniken und 20 Instituten das medizinische Hochleistungszentrum der Großregion und bietet international vernetzte Spitzenforschung. Jedes Jahr werden über 50.000 Patienten stationär und über 200.000 ambulant versorgt. Als einer der größten Arbeitgeber und Ausbilder des Saarlandes beschäftigen wir über 5 000 Beschäftigte, darunter u. a. 2 000 Pflegekräfte, rund 600 Ärztinnen und Ärzte und über 600 Auszubildende. An der Medizinischen Fakultät des Saarlandes studieren rund 2.000 Studentinnen und Studenten der Fächer Human- und Zahnmedizin, Human- und Molekularbiologie sowie Bioinformatik."

During the past decade, University of Saarland conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Saarland" #1 sponsor was "Universität des Saarlandes" with 9 trials, followed by "Association of Urologic Oncology (AUO)" with 3 trials sponsored, "Universitätsklinikum Hamburg-Eppendorf" with 2 trials sponsored, "Centre for Research and Technology Hellas" with 1 trials sponsored and "Dr. Marcus Unger" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Saarland" #1 collaborator was "Hannover Medical School" with 3 trials as a collaborator, "Universität des Saarlandes" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Ludwig-Maximilians - University of Munich" with 2 trials as a collaborator and "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "University of Saarland" are "Bladder Cancer" (2 trials), "Covid19" (2 trials), "Active Tuberculosis" (1 trials), "Acute Graft Rejection" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "University of Saarland" in a lesser frequency.

Most popular intervention types in "University of Saarland" are "Drug" (6 trials), "Dietary Supplement" (4 trials), "Other" (3 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "AAT( Alpha 1 Antitrypsin)" (1 trials), "Albuferon" (1 trials), "Aspirin" (1 trials), "Blood collection and electrophysiological tests" (1 trials) and "Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Saarland" are 22 trials for "All" genders.

Currently, there are NaN active trials in "University of Saarland". 1 are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in University of Saarland, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Saarland, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".